323 related articles for article (PubMed ID: 31623871)
1. Toward Clinical Implementation of Next-Generation Sequencing-Based Genetic Testing in Rare Diseases: Where Are We?
Liu Z; Zhu L; Roberts R; Tong W
Trends Genet; 2019 Nov; 35(11):852-867. PubMed ID: 31623871
[TBL] [Abstract][Full Text] [Related]
2. Implementation of Exome Sequencing to Identify Rare Genetic Diseases.
Udupa P; Ghosh DK
Methods Mol Biol; 2024; 2719():79-98. PubMed ID: 37803113
[TBL] [Abstract][Full Text] [Related]
3. Challenges in the diagnosis and discovery of rare genetic disorders using contemporary sequencing technologies.
Seaby EG; Ennis S
Brief Funct Genomics; 2020 Jul; 19(4):243-258. PubMed ID: 32393978
[TBL] [Abstract][Full Text] [Related]
4. The long tail and rare disease research: the impact of next-generation sequencing for rare Mendelian disorders.
Shen T; Lee A; Shen C; Lin CJ
Genet Res (Camb); 2015 Sep; 97():e15. PubMed ID: 26365496
[TBL] [Abstract][Full Text] [Related]
5. Exome/Genome Sequencing in Undiagnosed Syndromes.
Sullivan JA; Schoch K; Spillmann RC; Shashi V
Annu Rev Med; 2023 Jan; 74():489-502. PubMed ID: 36706750
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility in infants with suspected monogenic conditions through next-generation sequencing.
Hong S; Wang L; Zhao D; Zhang Y; Chen Y; Tan J; Liang L; Zhu T
Mol Genet Genomic Med; 2019 Jun; 7(6):e684. PubMed ID: 30968598
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for whole genome sequencing in diagnostics for rare diseases.
Souche E; Beltran S; Brosens E; Belmont JW; Fossum M; Riess O; Gilissen C; Ardeshirdavani A; Houge G; van Gijn M; Clayton-Smith J; Synofzik M; de Leeuw N; Deans ZC; Dincer Y; Eck SH; van der Crabben S; Balasubramanian M; Graessner H; Sturm M; Firth H; Ferlini A; Nabbout R; De Baere E; Liehr T; Macek M; Matthijs G; Scheffer H; Bauer P; Yntema HG; Weiss MM
Eur J Hum Genet; 2022 Sep; 30(9):1017-1021. PubMed ID: 35577938
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing rare diseases after the exome.
Frésard L; Montgomery SB
Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30559314
[TBL] [Abstract][Full Text] [Related]
9. Clinical validation of targeted next-generation sequencing for inherited disorders.
Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B
Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102
[TBL] [Abstract][Full Text] [Related]
10. Next-generation sequencing applied to rare diseases genomics.
Danielsson K; Mun LJ; Lordemann A; Mao J; Lin CH
Expert Rev Mol Diagn; 2014 May; 14(4):469-87. PubMed ID: 24702023
[TBL] [Abstract][Full Text] [Related]
11. Validation of copy number variation analysis for next-generation sequencing diagnostics.
Ellingford JM; Campbell C; Barton S; Bhaskar S; Gupta S; Taylor RL; Sergouniotis PI; Horn B; Lamb JA; Michaelides M; Webster AR; Newman WG; Panda B; Ramsden SC; Black GC
Eur J Hum Genet; 2017 Jun; 25(6):719-724. PubMed ID: 28378820
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis of genetic disorders in childhood with next-generation sequencing].
Menyhárt O; Győrffy B; Szabó A
Orv Hetil; 2022 Dec; 163(51):2027-2040. PubMed ID: 36528826
[TBL] [Abstract][Full Text] [Related]
13. Determining Cost-Optimal Next-Generation Sequencing Panels for Rare Disease and Pharmacogenomics Testing.
Katragadda S; Hall TO; Bettadapura R; Dalton JC; Ganapathy A; Ghana P; Hariharan R; Janakiraman A; Kotha KBVSSP; Manjunath A; Mannan AU; Ms N; Saraf S; Tzeng KTH; Veeramachaneni V
Clin Chem; 2021 Aug; 67(8):1122-1132. PubMed ID: 34120169
[TBL] [Abstract][Full Text] [Related]
14. A Diagnosis for All Rare Genetic Diseases: The Horizon and the Next Frontiers.
Boycott KM; Hartley T; Biesecker LG; Gibbs RA; Innes AM; Riess O; Belmont J; Dunwoodie SL; Jojic N; Lassmann T; Mackay D; Temple IK; Visel A; Baynam G
Cell; 2019 Mar; 177(1):32-37. PubMed ID: 30901545
[TBL] [Abstract][Full Text] [Related]
15. What Has the Undiagnosed Diseases Network Taught Us About the Clinical Applications of Genomic Testing?
Murdock DR; Rosenfeld JA; Lee B
Annu Rev Med; 2022 Jan; 73():575-585. PubMed ID: 35084988
[TBL] [Abstract][Full Text] [Related]
16. NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment.
Fernandez-Marmiesse A; Gouveia S; Couce ML
Curr Med Chem; 2018 Jan; 25(3):404-432. PubMed ID: 28721829
[TBL] [Abstract][Full Text] [Related]
17. [Application of Next-Generation Sequencing in Rare Renal Diseases].
Cai ZY; Zhao JR
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):484-490. PubMed ID: 35791948
[TBL] [Abstract][Full Text] [Related]
18. Next generation sequencing in neonatology: what does it mean for the next generation?
Janvier A; Barrington K; Lantos J
Hum Genet; 2022 May; 141(5):1027-1034. PubMed ID: 35348890
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic yield of exome and genome sequencing after non-diagnostic multi-gene panels in patients with single-system diseases.
Wilke MVMB; Klee EW; Dhamija R; Fervenza FC; Thomas B; Leung N; Hogan MC; Hager MM; Kolbert KJ; Kemppainen JL; Loftus EC; Leitzen KM; Vitek CR; McAllister T; Lazaridis KN; Pinto E Vairo F
Orphanet J Rare Dis; 2024 May; 19(1):216. PubMed ID: 38790019
[TBL] [Abstract][Full Text] [Related]
20. CNV Detection from Exome Sequencing Data in Routine Diagnostics of Rare Genetic Disorders: Opportunities and Limitations.
Royer-Bertrand B; Cisarova K; Niel-Butschi F; Mittaz-Crettol L; Fodstad H; Superti-Furga A
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
